Aqr Capital Management LLC Harpoon Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.94 - $2.56 $38,728 - $105,472	-41,200 Reduced 70.85%	16,954 $16,000
Q2 2022 Aug 15, 2022	BUY	$1.78 - $5.02 $58,421 - $164,761	32,821 Added 129.56%	58,154 $111,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $14,705 - $33,564	-4,154 Reduced 14.09%	25,333 $126,000
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $167,781 - $230,883	29,487 New	29,487 $223,000
Q1 2021 May 17, 2021	SELL	$17.65 - $24.16 $535,536 - $733,062	-30,342 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.83 - $17.84 $101,357 - $140,936	7,900 Added 35.2%	30,342 $504,000
Q3 2020 Nov 16, 2020	BUY	$11.01 - $18.52 $247,086 - $415,625	22,442 New	22,442 $381,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.